Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrations-Reference-Cited by-同舟云学术

Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrations

Published:2019-06-18 Issue:8 Volume:62 Page:698-705
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:Mycoses

Author:

Märtson Anne‐Grete¹,Veringa Anette¹,Heuvel Edwin R.²,Bakker Martijn³,Touw Daan J.¹,Werf Tjip S.⁴⁵,Span Lambert F. R.³,Alffenaar Jan‐Willem C.¹⁶^ORCID

Affiliation:

1. Department of Clinical Pharmacy and Pharmacology University Medical Center Groningen University of Groningen Groningen The Netherlands

2. Department of Mathematics and Computer Science Eindhoven University of Technology Eindhoven The Netherlands

3. Department of Hematology University Medical Center GroningenUniversity of Groningen Groningen The Netherlands

4. Department of Internal Medicine University Medical Center GroningenUniversity of Groningen Groningen The Netherlands

5. Department of Pulmonary Diseases and Tuberculosis University Medical Center GroningenUniversity of Groningen Groningen The Netherlands

6. Faculty of Medicine and Health, School of Pharmacy The University of SydneyWestmead Hospital Sydney New South Wales Australia

Funder

Merck Sharp and Dohme

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/myc.12948

Reference43 articles.

1. Aspergillosis

2. Recent advances in the treatment of life-threatening, invasive fungal infections

3. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

4. Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

5. Posaconazole: a broad-spectrum triazole antifungal

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoalbuminemia and Posaconazole Therapeutic Drug Monitoring;Open Forum Infectious Diseases;2024-08-09

2. Factors Influencing Serum Posaconazole Concentrations in Patients With Hematologic Malignancies Receiving Delayed-Release Tablets;Therapeutic Drug Monitoring;2024-04-04

3. Invasive fungal infection following venetoclax and posaconazole co‐administration;British Journal of Haematology;2023-09-20

4. Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO);Journal of Antimicrobial Chemotherapy;2023-06-13

5. Characterization of the interferences of systemic azole antifungal drugs with adrenal steroid biosynthesis using H295R cells and enzyme activity assays;Current Research in Toxicology;2023